Jenburkt Pharmaceuticals Ltd. - Quarterly/Annual Result Disclosures and Notes dated 31 Dec 2018

1. The Company has adopted Indian Accounting Standards (IND AS) prescribed under section 133 of the Companies Act, 2013, read with relevant rules issued thereunder from 1st April, 2017 and accordingly, these standalone unaudited financial results (including figures for the previous quarters and year ended 31st March, 2018) have been prepared in accordance with the recognition and measurement principles laid down in Ind AS.

2. The above statement of unaudited standalone financial results were reviewed by the Audit Committee and approved by the Board of directors at their respective meeting held on 5th February, 2019.

3. The company is dealing exclusively in Pharmaceuticals business segment, hence segmentwise reporting is not applicable.

4.The figures of the previous year/period have been regrouped/ recast/ rearranged to render them comparable with figures of the current period.